These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389 [TBL] [Abstract][Full Text] [Related]
4. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. Huestis MA; Cone EJ J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285 [TBL] [Abstract][Full Text] [Related]
5. Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop. Röhrich J; Schimmel I; Zörntlein S; Becker J; Drobnik S; Kaufmann T; Kuntz V; Urban R J Anal Toxicol; 2010 May; 34(4):196-203. PubMed ID: 20465865 [TBL] [Abstract][Full Text] [Related]
6. Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol. Cone EJ; Johnson RE; Darwin WD; Yousefnejad D; Mell LD; Paul BD; Mitchell J J Anal Toxicol; 1987; 11(3):89-96. PubMed ID: 3037193 [TBL] [Abstract][Full Text] [Related]
7. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH). Huestis MA; Henningfield JE; Cone EJ J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216 [TBL] [Abstract][Full Text] [Related]
8. Cannabinoids in blood and urine after passive inhalation of Cannabis smoke. Mørland J; Bugge A; Skuterud B; Steen A; Wethe GH; Kjeldsen T J Forensic Sci; 1985 Oct; 30(4):997-1002. PubMed ID: 2999292 [TBL] [Abstract][Full Text] [Related]
9. Passive inhalation of marihuana smoke and urinary excretion of cannabinoids. Perez-Reyes M; Di Guiseppi S; Mason AP; Davis KH Clin Pharmacol Ther; 1983 Jul; 34(1):36-41. PubMed ID: 6305545 [TBL] [Abstract][Full Text] [Related]
10. Driving Under the Influence of Marijuana Versus Driving and Dying Under the Influence of Marijuana: A Comparison of Blood Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol and Other Cannabinoids in Arrested Drivers Versus Deceased Drivers. Lemos NP; San Nicolas AC; Volk JA; Ingle EA; Williams CM J Anal Toxicol; 2015 Oct; 39(8):588-601. PubMed ID: 26378132 [TBL] [Abstract][Full Text] [Related]
11. Passive inhalation of cannabis smoke. Law B; Mason PA; Moffat AC; King LJ; Marks V J Pharm Pharmacol; 1984 Sep; 36(9):578-81. PubMed ID: 6149279 [TBL] [Abstract][Full Text] [Related]
12. Nonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects. Cone EJ; Bigelow GE; Herrmann ES; Mitchell JM; LoDico C; Flegel R; Vandrey R J Anal Toxicol; 2015 Sep; 39(7):497-509. PubMed ID: 26139312 [TBL] [Abstract][Full Text] [Related]
13. Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke. Cone EJ; Johnson RE Clin Pharmacol Ther; 1986 Sep; 40(3):247-56. PubMed ID: 3017628 [TBL] [Abstract][Full Text] [Related]
14. Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations. Moody DE; Monti KM; Crouch DJ J Anal Toxicol; 1992; 16(5):302-6. PubMed ID: 1338218 [TBL] [Abstract][Full Text] [Related]
15. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. Huestis MA; Henningfield JE; Cone EJ J Anal Toxicol; 1992; 16(5):276-82. PubMed ID: 1338215 [TBL] [Abstract][Full Text] [Related]
16. Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol. Hartman RL; Brown TL; Milavetz G; Spurgin A; Gorelick DA; Gaffney G; Huestis MA Clin Chem; 2015 Jun; 61(6):850-69. PubMed ID: 26019183 [TBL] [Abstract][Full Text] [Related]
17. GC/MS and EMIT analyses for delta 9-tetrahydrocannabinol metabolites in plasma and urine of human subjects. McBurney LJ; Bobbie BA; Sepp LA J Anal Toxicol; 1986; 10(2):56-64. PubMed ID: 3009969 [TBL] [Abstract][Full Text] [Related]
18. Screening for cannabinoids in blood using EMIT: concentrations of delta-9-tetrahydrocannabinol in relation to EMIT results. Gjerde H Forensic Sci Int; 1991; 50(1):121-4. PubMed ID: 1657743 [TBL] [Abstract][Full Text] [Related]
19. Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry. Andrenyak DM; Moody DE; Slawson MH; O'Leary DS; Haney M J Anal Toxicol; 2017 May; 41(4):277-288. PubMed ID: 28069869 [TBL] [Abstract][Full Text] [Related]